CLINICAL_TRIALS
trial_result
· 2022-06-27
Clinical Trial Update: Exenatide for Treating Cocaine Use Disorder [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial evaluating exenatide for cocaine use disorder has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The University of Texas Health Science Center, Houston | Conditions: Cocaine Use Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-06-27